Read Kris' Story Here

kris' story

Kris is one of our study's patient representative and he shares his story with The Herald here.

His experience and views help us shape the design and conduct of our research.

Follow us on Twitter

Our Research

We want to investigate how damage-associated molecular patterns (DAMPs) or ‘danger signals’ can be used as a biomarker test for patients with Crohn's disease or ulcerative colitis.

Why take part?

  • MUSIC runs in conjunction with your existing NHS treatment. It simply aims to monitor you much more closely as your condition hopefully improves.
  • It will be a learning opportunity for you. The more involved you are with your treatment, the more you will learn about your condition and how you can get back to full health as soon as possible.
  • You will be contributing to the latest research, the long term goal of which is to find more effective treatments and ultimately a cure for IBD.
who can take part

Who can take part?

We are looking for patients:

  • Age 16 and above
  • Have Crohn's disease or ulcerative colitis
  • Referred by their NHS doctor

What is involved?

This is a 12-month follow-up study which will involve appointments at 3 monthly intervals. We plan to closely monitor your clinical progress in line with the scientific work which we will carry out.

During the follow-up period, we will be gathering information on how you are doing and this information will be shared with your treating NHS clinician.

This may allow them to make treatment adjustments and check on how you're doing more closely than usual. For full details, please read the patient information sheet linked here.

  • Start
  • 3 months
  • 6 months
  • 9 months
  • 12 months

Participating Centres



Western General Hospital



Ninewells Hospital



Queen Elizabeth University Hospital

Our Sponsors